Abiraterone Acetate Tablet
Product Images NDC 0904-6948

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 0904-6948). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton Label (49809a29 6558 43a3 A347 5027de44aa41 00)

Carton Label (49809a29 6558 43a3 A347 5027de44aa41 00)
This is a description of a medication named ABIRATERONE ACETATE in the form of tablets, USP. The tablets are available in a unit dose pack containing 30 tablets. The pack also contains patent information which is needed to prevent abuse. The medicine may contain up to 250mg of ABIRATERONE. The insert found at aparmaceltiens.com contains necessary information on precautions to be taken while consuming the medicine. The medication needs to be stored at temperatures between 16°C to 30°C. No information is available on the use of this medication, and the user is advised to read the instructions mentioned in the package insert.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
The provided text is a table that shows the number of subjects without death over a period of time from randomization for two groups. The two groups are Placebo and Abiraterone acetate. The table shows the number of subjects for each group at each month from 3 to 60. The data has been split into two columns, one for each group. The first row shows the medication name and the subsequent rows detail the month from randomization.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
FDA Label Image

Figure 1 (Graph 1)

Figure 1 (Graph 1)
This appears to be a survival plot showing the percentage of survival over time (measured in months) for two groups - one group receiving a treatment called "Abiteron" and the other group receiving a placebo. The text seems to be showing the survival percentages at different time points for each group.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.